Homberg J C, Rizzetto M, Doniach D
Clin Exp Immunol. 1974 Aug;17(4):617-28.
A new ribosomal antibody is described in patients with systemic lupus erythematosus which reacts with all tissues from varied species, giving a distinctive immunofluorescence pattern. This can best be distinguished from other known autoantibodies on stomach where it reacts with chief cells and pancreas where exocrine cells are brightly stained. The ribosomal nature of the antigen was demonstrated by absorption of immunofluorescence and complement fixation studies using purified subcellular fractions. The antigen was unaffected by ribonuclease and was destroyed by trypsin, suggesting that it is one of the ribosomal proteins, while previously reported antibodies were mainly directed against ribosomal RNA, RNA–protein complexes, or polynucleotides and hybrids. The present ribosomal antibody is uncommon and occurs in less than 1% of SLE patients; its clinical significance is similar to that of ribosomal precipitins as the patients had renal involvement and several have died.
在系统性红斑狼疮患者中发现了一种新的核糖体抗体,它能与来自不同物种的所有组织发生反应,呈现出独特的免疫荧光模式。在胃中,该抗体与主细胞发生反应;在胰腺中,外分泌细胞被强烈染色,据此可将其与其他已知自身抗体进行最佳区分。通过使用纯化的亚细胞组分进行免疫荧光吸收和补体固定研究,证实了抗原的核糖体性质。该抗原不受核糖核酸酶影响,但可被胰蛋白酶破坏,这表明它是一种核糖体蛋白,而此前报道的抗体主要针对核糖体RNA、RNA - 蛋白质复合物或多核苷酸及杂交体。目前这种核糖体抗体并不常见,在不到1%的系统性红斑狼疮患者中出现;其临床意义与核糖体沉淀素相似,因为这些患者有肾脏受累情况,且有几例已死亡。